Inception Return
(7/23/1996)
|
7.85 %
|
|
YTD Return
|
6.45 %
|
|
NAVPS
(5/17/2024)
|
$55.71
|
|
Change
|
($0.04) / -0.07 %
|
|
|
Growth of $10,000
(As of April 30, 2024)
|
|
MER
|
2.34 %
|
|
Assets ($mil)
|
$155.82
|
|
Rank (1Yr)
|
116/171
|
|
Std Dev (3Yr)
|
16.66 %
|
|
Volatility Ranking (3Yr)
|
5/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or No Load
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
This fund’s objective is to obtain maximum long-term capital growth. It invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry. This includes companies that provide goods and services to these companies and companies that the portfolio adviser believes would benefit from developments in the health sciences industry.
|
Fund Manager
CI Global Asset Management
Portfolio Manager
Peter Hofstra, CI Global Asset Management
Kevin McSweeney, CI Global Asset Management
Greg Quickmre, CI Global Asset Management
Sub-Advisor
Data not available
|
|
Asset Allocation
(As of April 30, 2024)
|
Sector Allocation
(As of April 30, 2024)
|
Geographic Allocation
(As of April 30, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Eli Lilly and Co | US Equity | Healthcare | United States | 10.37% |
| UnitedHealth Group Inc | US Equity | Healthcare | United States | 9.45% |
| Novo Nordisk A/S Cl B | International Equity | Healthcare | European Union | 7.60% |
| Merck & Co Inc | US Equity | Healthcare | United States | 6.62% |
| AstraZeneca PLC | International Equity | Healthcare | European Union | 6.35% |
| Thermo Fisher Scientific Inc | US Equity | Healthcare | United States | 4.97% |
| Anthem Inc | US Equity | Healthcare | United States | 4.87% |
| Abbvie Inc | US Equity | Healthcare | United States | 4.26% |
| Zoetis Inc Cl A | US Equity | Healthcare | United States | 4.25% |
| Cigna Corp | US Equity | Healthcare | United States | 4.06% |
Performance Data
(As of April 30, 2024)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-2.57
|
3.83
|
10.09
|
6.45
|
6.59
|
1.29
|
4.66
|
4.03
|
|
Benchmark
|
-1.82
|
4.10
|
16.91
|
4.68
|
8.73
|
7.59
|
8.86
|
7.22
|
|
Quartile Ranking
|
2
|
3
|
4
|
2
|
3
|
3
|
4
|
4
|
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
Fund
|
2.65
|
-1.18
|
-0.08
|
11.20
|
12.00
|
1.11
|
6.44
|
-19.15
|
14.12
|
19.59
|
|
Benchmark
|
11.75
|
-5.84
|
25.09
|
5.60
|
22.88
|
-8.89
|
9.10
|
21.08
|
-8.32
|
10.55
|
|
Quartile Ranking
|
3
|
1
|
4
|
3
|
4
|
3
|
4
|
4
|
3
|
3
|